# Handoff: Idea 003 Gate 01 Closure and Post-Negative Ideation

## Current state

Idea `003-prescription-relative-confidence` Gate 01 has completed formal execution on `319-lab-via-server`, passed independent integrity audit, and reached the authoritative research decision to terminate:

- **Idea ID**: `003-prescription-relative-confidence`
- **Idea Status**: `CLOSED (Gate 01 Falsified)`
- **Gate 01 Status**: `EXECUTED / FALSIFIED`
- **Formal Verdict**: `STOP_NO_INCREMENTAL_PRESCRIPTION_RELATIVE_CONFIDENCE` (`TERMINATE_IDEA_003`)
- **Protocol**: [`research/ideas/003-prescription-relative-confidence/experiments/gate-01-prescription-relative-confidence.md`](research/ideas/003-prescription-relative-confidence/experiments/gate-01-prescription-relative-confidence.md)
- **Design Audit**: [`research/ideas/003-prescription-relative-confidence/experiments/gate-01-design-integrity-audit.md`](research/ideas/003-prescription-relative-confidence/experiments/gate-01-design-integrity-audit.md) (`INTEGRITY_PASS`)
- **Integrity Audit**: [`research/ideas/003-prescription-relative-confidence/experiments/gate-01-integrity-audit.md`](research/ideas/003-prescription-relative-confidence/experiments/gate-01-integrity-audit.md) (`INTEGRITY_PASS`)
- **Research Decision**: [`research/ideas/003-prescription-relative-confidence/research-decision.md`](research/ideas/003-prescription-relative-confidence/research-decision.md)
- **Failure Record**: [`research/memory/failures/prescription-relative-confidence-gate-01--no-incremental-relative-confidence.md`](research/memory/failures/prescription-relative-confidence-gate-01--no-incremental-relative-confidence.md)
- **Public Summary**: [`research/ideas/003-prescription-relative-confidence/experiments/gate-01-summary.json`](research/ideas/003-prescription-relative-confidence/experiments/gate-01-summary.json)
- **Formal Run ID**: `gate-01-prescription-relative-confidence-20260902-233128`
- **Harness Revision**: `ac9dfe860bbce7a9a9620cf21836931136582055`
- **Completion Commit**: `99702ac54115111e55cce44d5392029127dcf40f`
- **Test Split**: Strictly unindexed, unpredicted, and untouched.

## Executed 319 Run Summary

Formal execution was carried out on `319-lab-via-server` under `medrec-core-evaluator`:

- **Audit Cohort Support**: 7,740 candidates from 423 eligible patients ($N_{PB=1}=417$, $N_{PB=0}=423$, both $\ge 50$; $k(10\%)=774$, $k(20\%)=1,548$). Gate A passed.
- **Audit Policy Yields**:
  - `Random`: 31.37% (0.313695)
  - `ScoreOnly`: 56.85% (10%), 55.88% (20%), 54.87% (30%)
  - `StrongControl`: 57.49% (10%), 57.17% (20%), 55.30% (30%)
  - `RankAugmented`: 57.24% (10%), 56.91% (20%), 55.00% (30%)
  - `Oracle`: 100.0% across all budgets
- **Gaps & Bootstrap 95% CIs (1,000 patient-cluster replicates, seed `1203`)**:
  - `Oracle - StrongControl` (Gate B): $+42.51\%$ (10%, CI $[+39.04\%, +46.15\%]$); $+42.83\%$ (20%, CI $[+40.34\%, +45.78\%]$). Lower bounds strictly $> 0$; Gate B passed.
  - `RankAugmented - StrongControl` (Gate C): $-0.26\%$ (10%, CI $[-1.37\%, +1.19\%]$); $-0.26\%$ (20%, CI $[-0.65\%, +0.80\%]$). Lower bounds $\le 0$; Gate C failed.

## Cumulative Knowledge Across Ideas 001, 002, 003

1. **Idea 001**: The preregistered active-DDI-degree scalar and Tension interaction did not establish incremental routing information beyond frozen recommender confidence under the recorded setting.
2. **Idea 002**: The preregistered five-bin Dev-fitted score map induced the same ordering as `ScoreOnly` and provided zero incremental routing yield.
3. **Idea 003**: The preregistered within-prescription mid-rank observable did not establish incremental routing information beyond its frozen `StrongControl`.
4. **Scoped negative evidence**: These results terminate those tested routes. They do not establish that all single-visit, relational, temporal, structural, DDI-derived, or patient-conditioned observables have been exhausted.
5. **Residual question**: Substantial retrospective `Oracle - StrongControl` headroom shows false-positive outcome heterogeneity that is not explained by the frozen control. Because Oracle uses the target, this does not establish that a target-free observable mechanism exists or identify its information source.

## Post-Idea-003 Research Stage

No Idea 004 has been selected or authorized.

The next scientific task is renewed hypothesis selection from the scoped residual question:

$$
\boxed{\text{What target-free observable information, not already tested in Ideas 001--003, explains residual medication-level false-positive heterogeneity beyond the frozen strong control?}}
$$

Longitudinal prescription transition status is one candidate information source, not the default successor. It must compete against materially different hypotheses after current closest-work search. Other legitimate candidates may include transparent medication-set relational statistics, patient-conditioned observables, or cross-model evidence, provided each introduces genuinely new observable information and faces its strongest simple control.

## Next CCFA owners

1. `ccf-pipeline-orchestrator` — confirm post-negative-result idea-selection stage and evidence boundaries.
2. `ccf-literature-monitor` / `ccf-literature-searcher` — update recent work and closest prior art for the candidate information sources.
3. `ccf-idea-optimizer` in exploratory mode — generate 3–5 coherent, falsifiable candidates without scoring.
4. `ccf-idea-reviewer` in standard mode — perform explicit literature-grounded ranking and select a winner only if one survives strict review.
5. `ccf-idea-optimizer` in standard mode — concretize only the selected winner.
6. `ccf-experiment-designer` — design the cheapest decisive Gate 01 only after Idea 004 is selected.

Do not create an Idea 004 directory, design a Gate, or execute 319 work before this selection sequence is complete.
